Ban on Pioglitazone, an anti-diabetic medicine revoked in India
The Union Health Ministry had banned the sale
of Pioglitazone, an anti-diabetic medicine with a Rs. 830 crore market in India
last June (2013). However, the ban has been lifted after the recommendation of
an expert group.
